Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2013-04-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
2012年日常关联交易执行情况及2013年日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's related party transactions executed in 2012 and the expected related party transactions for 2013. It includes transaction amounts, related parties' descriptions, pricing policies, impact analysis, board meeting resolutions, and independent directors' opinions. The document is an announcement of related party transactions and their expected amounts, which is typical for regulatory disclosures about ongoing or planned related party dealings. It is not a full financial report, audit report, or earnings release. It is also not a voting result or management change announcement. The document is a regulatory announcement about related party transactions, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories and is a compliance disclosure under Shenzhen Stock Exchange rules.
2013-04-17 Chinese
2012年度财务决算报告
Annual Report Classification · 95% confidence The document is titled '2012 年度财务决算报告' which translates to '2012 Annual Financial Settlement Report'. It contains detailed financial data including total assets, liabilities, net assets, revenue, profit, and cash flow for the year ending December 31, 2012. The presence of comprehensive financial statements and analysis for a full fiscal year indicates this is an annual report. The document length is 2209 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, it is classified as an Annual Report (10-K equivalent). FY 2012
2013-04-17 Chinese
2012年度证券投资专项说明
Regulatory Filings Classification · 85% confidence The document is titled '2012年度证券投资专项说明' which translates to '2012 Annual Securities Investment Special Explanation'. It details the company's securities investment activities during the year 2012, including investment amounts, securities held, gains/losses, and internal control measures. It includes tables of securities holdings and investment performance, as well as an independent director's opinion on compliance and internal controls. The document is a detailed report on securities investment activities for the year, not a brief announcement or a certification. It does not contain full financial statements or comprehensive company-wide financial performance, so it is not an Annual Report (10-K) or Interim Report (IR). It is a specialized report focusing on securities investment activities and internal controls for the year. This fits best with the category of Regulatory Filings (RNS) as it is a regulatory disclosure about securities investment activities and compliance, but does not fit other more specific categories like Capital/Financing Update or Audit Report. The document length is 3094 characters, which is relatively short but contains substantive content rather than just an announcement or certification. Therefore, the best classification is Regulatory Filings (RNS).
2013-04-17 Chinese
2012年年度报告
Annual Report Classification · 100% confidence The document is titled "北京双鹭药业股份有限公司 2012 年度报告全文" which translates to "Beijing SL Pharmaceutical Co., Ltd. 2012 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data and indicators, board of directors report, risk disclosures, accounting policies, financial statements, and other comprehensive information. The document covers the full fiscal year 2012 (January 1 to December 31) and includes extensive financial data, management discussion, and analysis. It is not a brief announcement or a presentation but a full detailed report. Therefore, this document fits the definition of an Annual Report (10-K). FY 2012
2013-04-17 Chinese
关于监事辞职的公告
Board/Management Information Classification · 95% confidence The document is a short announcement regarding the resignation of a company supervisor (监事) due to retirement. It includes details about the resignation, the legal implications for the board, and a statement of thanks. There is no financial data, no mention of a report being published or attached, and no indication of a meeting or voting results. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2013-04-17 Chinese
监事会对公司2012年内部控制自我评价报告的意见
Audit Report / Information Classification · 95% confidence The document is an opinion statement from the Supervisory Board regarding the company's 2012 internal control self-evaluation report. It references regulatory guidelines and confirms the effectiveness and completeness of internal controls for the year 2012. The document is a formal audit-related opinion on internal controls rather than the full internal control report itself or a general annual report. It fits the category of an Audit Report / Information (AR), which includes audit opinions and internal control evaluations separate from the full annual report. The document length is short but contains substantive content related to internal control audit opinion, not just an announcement or certification. Therefore, the classification is AR with high confidence. FY 2012
2013-04-17 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.